EMAIL THIS PAGE TO A FRIEND

Annals of Hematology

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.


PMID 24687382

Abstract

We're sorry this abstract is currently not available.